Evidence map›Paper›PMID 39251236›Full record

ArticleBMJ global health2024

Training health workers and community influencers to be Vaccine Champions: a mixed-methods RE-AIM evaluation.

Jessica Kaufman, Isabella Overmars, James Fong, Jemesa Tudravu, Rachel Devi, Litiana Volavola, Luisa Vodonaivalu, Kylie Jenkins, Julie Leask, Holly Seale and 7 more

Abstract read
In one paragraph

Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Developing Community-Informed Communication Resources to Improve Human Papillomavirus Vaccine Uptake in Tonga.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jessica KaufmanVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia jess.kaufman@mcri.edu.au.ORCID http://orcid.org/0000-0001-5139-4183
Isabella OvermarsVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
James FongRepublic of Fiji Ministry of Health, Suva, Rewa, Fiji.
Jemesa TudravuRepublic of Fiji Ministry of Health, Suva, Rewa, Fiji.
Rachel DeviRepublic of Fiji Ministry of Health, Suva, Rewa, Fiji.
Litiana VolavolaRepublic of Fiji Ministry of Health, Suva, Rewa, Fiji.
Luisa VodonaivaluVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Kylie JenkinsVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Julie LeaskSchool of Public Health, The University of Sydney Faculty of Medicine and Health, Camperdown, New South Wales, Australia.ORCID http://orcid.org/0000-0001-5095-1443
Holly SealeSchool of Population Health, University of New South Wales, Sydney, New South Wales, Australia.
Yasmin MohamedVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Kshitij JoshiUNICEF Pacific, Suva, Fiji.
Halitesh DattUNICEF Pacific, Suva, Fiji.
Sonya SaganUNICEF Pacific, Suva, Fiji.
Michelle DynesUNICEF East Asia and Pacific Regional Office, Bangkok, Thailand.
Monsurul HoqVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Margie DanchinVaccine Uptake Group, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIncreasing trust and confidence in vaccines is a global priority, as countries have grappled with delivering COVID-19 vaccines, maintaining routine childhood vaccination rates and introducing new vaccines. Community-based vaccine promotion interventions are commonly implemented, but effectiveness evidence is limited. In 2022, supported by the Australian Government and in partnership with Fiji's Ministry of Health and UNICEF, we codesigned, delivered and comprehensively evaluated a vaccine education and communication training programme for health workers and community influencers to promote COVID-19 and routine immunisation.

methodsThe Vaccine Champions programme included three phases: (1) codesign with Fiji stakeholders; (2) vaccine education and communication training for Vaccine Champions and (3) support for Champions to deliver community vaccine discussion sessions over 6 months.The RE-AIM framework evaluation measured programme reach, effectiveness, adoption, implementation and maintenance. Mixed-methods data were collected through interviews, surveys and field notes, integrating qualitative and quantitative data to triangulate findings. Primary outcomes included Champions' knowledge, communication self-efficacy, trust in COVID-19 vaccines, programme satisfaction and community members' intention to vaccinate.

resultsWe trained 35 Champions (27/35 female), including health workers, faith and community influencers. Half had a health background (17/35). Champions conducted 54 discussion sessions, reaching 1717 community members. Most Champions (22/35) conducted at least 1 session, with 16 running 3 or more. Champions who did not run sessions reported barriers like lack of confidence and competing duties. Training increased Champions' communication self-efficacy and trust in COVID-19 vaccines. Community member intention to vaccinate increased from 41% (394/960) to 83% (822/991) before and after a session. The programme was well received with interest in continued engagement.

conclusionTraining health workers and community Vaccine Champions can promote vaccine confidence. Programmes require government support and engagement for sustainability. Robust evaluation frameworks are needed to build the evidence base.

Indexed as

COVID-19COVID-19 VaccinesAdultFemaleFijiHealth PersonnelHumansImmunization ProgramsMaleMiddle AgedProgram EvaluationSARS-CoV-2TrustVaccinationCOVID-19 VaccinesCOVID-19health education and promotionimmunisationpublic health

Identifiers

PMID39251236
PMCPMC11733790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.